Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY-NCAlzheimer's & dementia (Amsterdam, Netherlands)

Digital completion time relates more strongly to Alzheimer's disease-type atrophy than to vascular burden in a community cohort.

  1. 1Department of Neurology Faculty of Medicine Shimane University Izumo Japan.

Abstract

Introduction

Slowing on digital cognitive testing may reflect Alzheimer's disease (AD)-type atrophy, small-vessel disease, or both. Single-outcome studies cannot determine whether slowing preferentially reflects one type of brain change or general brain health. We tested whether response-time features from the tablet-based Cognitive Assessment for Dementia, iPad version 2 (CADi2) were more strongly associated with AD-type atrophy than with vascular burden.Methods

In 1163 community-dwelling adults undergoing brain-health screening (Izumo cohort, 2019-2025), CADi2 response-time features predicted two primary MRI markers from one framework under repeated nested cross-validation: Alzheimer's disease likelihood score (ADLS; similarity to an AD-type atrophy pattern) and normalized white matter lesion (WML) volume. The primary metric was the incremental observed-predicted correlation (ΔR) over age and sex. Silent brain infarcts, microbleeds, and a composite small vessel disease score were additional vascular outcomes.Results

CADi2 features improved prediction of ADLS (ΔR = +0.054, 95% confidence interval [CI] +0.010 to +0.095) but not WML (ΔR = -0.006). The improvement reflected completion time, not accuracy. Because predictive headroom differed, we repeated the comparison in residual space. There, the increment correlated about twice as strongly with ADLS as with WML (r = 0.160 vs. 0.080; p = 0.044), although both remained significant. A parallel contrast against the composite vascular score gave Δr = 0.100 (p = 0.008).Discussion

Digital completion time was preferentially, but not exclusively, associated with AD-type atrophy (neurodegeneration axis) relative to vascular burden. Because ADLS indexes an atrophy pattern rather than amyloid or tau pathology, these cross-sectional findings characterize a structural phenotype.

Related

  1. Genetic Associations with Alzheimer's, Lewy Body and Vascular Neuropathology Reveal Shared and Distinct Biological Pathways
    K. Morgan, A. Thomas, K. J. Brookes
    medRxivPreprintAll rights reservedFull textHuman geneticsmedRxiv
  2. Vascular brain injury modifies the relationship between sleep duration, cognition, and white matter hyperintensity burden in the Alzheimer's disease continuum
    Soraya Lahlou, Zahinoor Ismail, Eric E. Smith +2
    Alzheimer's & dementia : the journal of the Alzheimer's AssociationPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Alzheimer’s disease research must connect vascular molecular phenotypes with physiology
    Thomas S Lewis, Jessica Wagner, Jonas J Neher
    PLOS BiologyPeer-reviewedCC BYFull textGeneral biochemistryCell biologyPLOSEurope PMCPMC
  4. Rare extreme polygenic risk scores strongly indicate Alzheimer's disease risk
    E. L. Ward, P. T. Nelson, Y. Katsumata +4
    medRxivPreprintCC BY-NCFull textHuman geneticsmedRxiv
  5. Blood transcriptomic signatures of vascular risk in Alzheimer's disease
    Sang‐Won Han, Young Ho Park, Jung‐Min Pyun +4
    Alzheimer's & DementiaPeer-reviewedCC BY-NC-ND 4.0Full textPsychiatry & mental healthPMCEurope PMC
BibTeX
@article{iwasa2026digital,
  title = {{Digital completion time relates more strongly to Alzheimer's disease-type atrophy than to vascular burden in a community cohort.}},
  author = {Kenichi Iwasa and Naoki Omori and Manabu Ishida and Tomotaka Tanaka and Atsushi Nagai},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year = {2026},
  month = oct,
  doi = {10.1002/dad2.70526},
  url = {https://europepmc.org/article/MED/42948203},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Digital completion time relates more strongly to Alzheimer's disease-type atrophy than to vascular burden in a community cohort.
AU  - Kenichi Iwasa
AU  - Naoki Omori
AU  - Manabu Ishida
AU  - Tomotaka Tanaka
AU  - Atsushi Nagai
PY  - 2026
DA  - 2026/10/26
JO  - Alzheimer's & dementia (Amsterdam, Netherlands)
DO  - 10.1002/dad2.70526
UR  - https://europepmc.org/article/MED/42948203
AB  - Introduction  Slowing on digital cognitive testing may reflect Alzheimer's disease (AD)-type atrophy, small-vessel disease, or both. Single-outcome studies cannot determine whether slowing preferentially reflects one type of brain change or general brain health. We tested whether response-time features from the tablet-based Cognitive Assessment for Dementia, iPad version 2 (CADi2) were more strongly associated with AD-type atrophy than with vascular burden.Methods  In 1163 community-dwelling adults undergoing brain-health screening (Izumo cohort, 2019-2025), CADi2 response-time features predicted two primary MRI markers from one framework under repeated nested cross-validation: Alzheimer's disease likelihood score (ADLS; similarity to an AD-type atrophy pattern) and normalized white matter lesion (WML) volume. The primary metric was the incremental observed-predicted correlation (ΔR) over age and sex. Silent brain infarcts, microbleeds, and a composite small vessel disease score were additional vascular outcomes.Results  CADi2 features improved prediction of ADLS (ΔR = +0.054, 95% confidence interval [CI] +0.010 to +0.095) but not WML (ΔR = -0.006). The improvement reflected completion time, not accuracy. Because predictive headroom differed, we repeated the comparison in residual space. There, the increment correlated about twice as strongly with ADLS as with WML (r = 0.160 vs. 0.080; p = 0.044), although both remained significant. A parallel contrast against the composite vascular score gave Δr = 0.100 (p = 0.008).Discussion  Digital completion time was preferentially, but not exclusively, associated with AD-type atrophy (neurodegeneration axis) relative to vascular burden. Because ADLS indexes an atrophy pattern rather than amyloid or tau pathology, these cross-sectional findings characterize a structural phenotype.
SN  - 2352-8729
ER  -